Palliative Care and Parkinson's Disease: Time to Move Beyond Cancer.

Abstract

Movement DisordersVolume 36, Issue 6 p. 1325-1329 Viewpoint Palliative Care and Parkinson's Disease: Time to Move Beyond Cancer Benzi M. Kluger MD, MS, Corresponding Author benzi_kluger@urmc.rochester.edu Departments of Neurology and Medicine, University of Rochester Medical Center, Rochester, New York, USA Correspondence to: Prof. Benzi M. Kluger, Departments of Neurology and Medicine, University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420694, Rochester, NY 14618, USA; E-mail: benzi_kluger@urmc.rochester.eduSearch for more papers by this authorRachel Dolhun MD, The Michael J. Fox Foundation, New York, New York, USASearch for more papers by this authorMalenna Sumrall PhD, Parkinson Foundation Patient and Family Advisory Council, New York, New York, USASearch for more papers by this authorKirk Hall MBA, Parkinson Foundation Patient and Family Advisory Council, New York, New York, USASearch for more papers by this authorMichael S. Okun MD, Department of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA Parkinson's Foundation, Miami, Florida, USASearch for more papers by this author Benzi M. Kluger MD, MS, Corresponding Author benzi_kluger@urmc.rochester.edu Departments of Neurology and Medicine, University of Rochester Medical Center, Rochester, New York, USA Correspondence to: Prof. Benzi M. Kluger, Departments of Neurology and Medicine, University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420694, Rochester, NY 14618, USA; E-mail: benzi_kluger@urmc.rochester.eduSearch for more papers by this authorRachel Dolhun MD, The Michael J. Fox Foundation, New York, New York, USASearch for more papers by this authorMalenna Sumrall PhD, Parkinson Foundation Patient and Family Advisory Council, New York, New York, USASearch for more papers by this authorKirk Hall MBA, Parkinson Foundation Patient and Family Advisory Council, New York, New York, USASearch for more papers by this authorMichael S. Okun MD, Department of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA Parkinson's Foundation, Miami, Florida, USASearch for more papers by this author First published: 30 March 2021 https://doi.org/10.1002/mds.28556 Relevant conflicts of interest/financial disclosures:: B.M.K. has received research grant support from the National Institute of Aging, National Institute of Nursing Research, and Patient-Centered Outcomes Research Institute; he has received speaker honoraria from the Parkinson's Foundation. R.D. has nothing to report. M.S. has received support as a care partner stakeholder from the Patient-Centered Outcomes Research Institute. K.H. has received support as a patient stakeholder from the Patient-Centered Outcomes Research Institute. M.S.O. serves as a consultant for the Parkinson's Foundation and has received research grants from the NIH, Parkinson's Foundation, The Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. M.S.O.'s deep brain stimulation research is supported by NIH grants R01 NR014852 and R01 NS096008. M.S.O. is the primary investigator (PI) of the NIH R25NS108939 Training Grant; has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, Perseus, Robert Rose, Oxford, and Cambridge (movement disorders books); is an associate editor for New England Journal of Medicine Journal Watch Neurology; has participated in Continuing Medical Education and educational activities on movement disorders sponsored by the Academy for Healthcare Learning, PeerView, Prime, QuantiaMD, WebMD/Medscape, Medicus, MedNet, Einstein, MedNet, Henry Stewart, American Academy of Neurology, Movement Disorders Society, and Vanderbilt University. The institution and not M.S.O. receives grants from Medtronic, AbbVie, Boston Scientific, Abbott, and Allergan, and the PI has no financial interest in these grants. M.S.O. has participated as a site PI and/or coinvestigator for several NIH-, foundation-, and industry-sponsored trials over the years but has not received honoraria. Research projects at the University of Florida receive device and drug donations. Full financial disclosures and author roles may be found in the online version of this article. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Volume36, Issue6June 2021Pages 1325-1329 RelatedInformation